Rokson Pharmaceuticals Private Limited
About Rokson Pharmaceuticals Private Limited
Data last updated:
Rokson Pharmaceuticals Private Limited is a private limited company based in Nagpur, Maharashtra, India. The company is currently under process of striking off by the Registrar of Companies. The removal process has been initiated but is not yet final, and the company may be struck off soon. It operates in the ayurvedic products and services segment of the healthcare sector. It was incorporated on 24 February 2011.
The company is registered with the Registrar of Companies (ROC), Nagpur, under CIN U24230MH2011PTC213998. The company has 2 GST registrations on record, none of which is active.
The company has an authorised share capital of ₹2 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Poonam Sunil Mishra and Sunil Shatrughan Mishra.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Plot No. 55 Netaji Society Near Nisarg Garden Lawn Katol Road, Nagpur, Maharashtra, India – 440013.
As per the financials filed for FY 2024, the company reported a revenue of ₹2 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹1.63 Lakh (net margin 81.4%) and EBITDA of ₹1.66 Lakh (EBITDA margin 82.8%). Revenue has grown at a compounded annual rate (CAGR) of 102% over three years and 54% over five years.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressPlot No. 55 Netaji Society Near Nisarg Garden Lawn Katol Road, Nagpur, Maharashtra, India – 440013
- IndustryHealthcare, Ayurvedic Products & Services
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Rokson Pharmaceuticals Private Limited FY 2024 filings available
Rokson Pharmaceuticals Private Limited reported revenue of ₹2 Lakh (up 300% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Rokson Pharmaceuticals Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 54% over five years, including 300% growth in the latest year. EBITDA rose 436% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Rokson Pharmaceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹1.66 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹1.63 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Rokson Pharmaceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 82.8% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 81.4% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Rokson Pharmaceuticals are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Rokson Pharmaceuticals Private Limited
Rokson Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Poonam Sunil Mishra Also directs: Prithvi International Private Limited | Director | 24 Feb 2011 | 15 Years 7 Months | Current |
| Sunil Shatrughan Mishra | Director | 24 Feb 2011 | 15 Years 7 Months | Current |
Peer Comparison of Rokson Pharmaceuticals Private Limited
Rokson Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Healthcare industry (Ayurvedic Products and Services, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Devam Ayurveda Private Limited | ₹2.02 Lakh (FY 2025) | •••• | •••• | 0.0% | •••• | Lucknow, Uttar Pradesh, India |
| Redify Global Solutions Private Limited | ₹2.02 Lakh (FY 2024) | •••• | •••• | -23.0% | •••• | Ernakulam, Kerala, India |
| Yryr Ayurvedic Multitrading Private Limited | ₹2.02 Lakh (FY 2022) | •••• | •••• | -67.0% | •••• | Agra, Uttar Pradesh, India |
| Indmed Pharmaceuticals Limited | ₹2.01 Lakh (FY 2018) | •••• | •••• | -78.0% | •••• | Indore, Madhya Pradesh, India |
| Goodhealth Herbal Private Limited | ₹2 Lakh (FY 2024) | •••• | •••• | -14.0% | •••• | Kolkata, West Bengal, India |
| Rokson Pharmaceuticals Private Limited this company | ₹2 Lakh (FY 2024) | •••• | •••• | 300.0% | •••• | Nagpur, Maharashtra, India |
| Sandex Pharmaceuticals Private Limited | ₹2 Lakh (FY 2025) | •••• | •••• | •••• | Karunagappally, Kerala, India | |
| Neosun Pharmaceuticals Private Limited | ₹2 Lakh (FY 2025) | •••• | •••• | -59.0% | •••• | Aurangabad, Maharashtra, India |
| Human Food Chemical and Drug Pharmaceuticals Private Limited | ₹1.99 Lakh (FY 2021) | •••• | •••• | 71.0% | •••• | Ghazipur, Uttar Pradesh, India |
| Apotheca Pharmaceuticals Private Limited | ₹1.98 Lakh (FY 2024) | •••• | •••• | -46.0% | •••• | Hyderabad, Telangana, India |
| Steprise Pharmaceuticals Private Limited | ₹1.98 Lakh (FY 2023) | •••• | •••• | 9.0% | •••• | Kolkata, West Bengal, India |
Peers are the five companies nearest above and the five nearest below Rokson Pharmaceuticals by revenue in the Healthcare industry (Ayurvedic Products and Services, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Rokson Pharmaceuticals Private Limited
Rokson Pharmaceuticals Private Limited is audited by AMIT R SURANA & CO for the financial year 2020.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| AMIT R SURANA & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Rokson Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Rokson Pharmaceuticals Private Limited
Rokson Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Rokson Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Rokson Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Rokson Pharmaceuticals Private Limited
Rokson Pharmaceuticals Private Limited has 4 board changes on record since 2011: 2 appointments and 2 cessations. The latest: Sangit Ashokrao Chauhan ceased to be Director on 09 Apr 2019.
Credit Ratings, Litigation & Regulatory Alerts for Rokson Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Rokson Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Rokson Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Rokson Pharmaceuticals Private Limited
Rokson Pharmaceuticals has 2 GST registrations on record, and all of them have been cancelled or are inactive. Only active GST numbers are listed on this page.
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Rokson Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rokson Pharmaceuticals Private Limited
Rokson Pharmaceuticals is currently "Under Process of Striking Off" as per MCA records. The Registrar of Companies has initiated the process to remove the company from the register, typically due to non-filing of statutory returns. This process is not yet final, but the company may be struck off soon. Caution is advised before entering into any agreements with this entity.
Rokson Pharmaceuticals is a company pending strike off, currently registered as a private limited company based in Nagpur, Maharashtra, India. The company works in ayurvedic products and services, within the healthcare industry. It was incorporated on 24 February 2011 and is registered under CIN U24230MH2011PTC213998. The company may be struck off soon - caution is advised.
The compliance status of Rokson Pharmaceuticals is compliant as of 14 July 2026.
Rokson Pharmaceuticals has 2 current directors:
- Poonam Sunil Mishra - Director
- Sunil Shatrughan Mishra - Director
The CIN (Corporate Identification Number) of Rokson Pharmaceuticals is U24230MH2011PTC213998. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Rokson Pharmaceuticals was incorporated on 24 February 2011. It is registered with the Registrar of Companies, Nagpur.
The registered office of Rokson Pharmaceuticals is at Plot No. 55 Netaji Society Near Nisarg Garden Lawn Katol Road, Nagpur, Maharashtra, India – 440013.
Rokson Pharmaceuticals reported revenue of ₹2 Lakh for FY 2024 (up 300% YoY).
Rokson Pharmaceuticals has an authorised share capital of ₹2 Lakh and a paid-up capital of ₹1 Lakh.
Rokson Pharmaceuticals reported a net profit of ₹1.63 Lakh (net margin 81.4%) and EBITDA of ₹1.66 Lakh (EBITDA margin 82.8%) for FY 2024, as per its filed financial statements.
No. Rokson Pharmaceuticals has 2 GST registrations on record and all of them are cancelled or inactive.